Logo image of TRON

TRON INC (TRON) Stock Fundamental Analysis

USA - NASDAQ:TRON - US85237B1017 - Common Stock

2.98 USD
-0.02 (-0.83%)
Last: 9/16/2025, 8:00:01 PM
3.05 USD
+0.07 (+2.35%)
After Hours: 9/16/2025, 8:00:01 PM
Fundamental Rating

1

Taking everything into account, TRON scores 1 out of 10 in our fundamental rating. TRON was compared to 33 industry peers in the Leisure Products industry. Both the profitability and financial health of TRON have multiple concerns. TRON is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

TRON had positive earnings in the past year.
In the past year TRON has reported a negative cash flow from operations.
TRON Yearly Net Income VS EBIT VS OCF VS FCFTRON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M 4M -4M 6M

1.2 Ratios

TRON has a Return On Assets of 12.69%. This is amongst the best in the industry. TRON outperforms 96.97% of its industry peers.
Industry RankSector Rank
ROA 12.69%
ROE N/A
ROIC N/A
ROA(3y)2.01%
ROA(5y)N/A
ROE(3y)1.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRON Yearly ROA, ROE, ROICTRON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

TRON does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TRON Yearly Profit, Operating, Gross MarginsTRON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

3

2. Health

2.1 Basic Checks

The number of shares outstanding for TRON has been reduced compared to 1 year ago.
TRON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TRON Yearly Shares OutstandingTRON Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M
TRON Yearly Total Debt VS Total AssetsTRON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M

2.2 Solvency

An Altman-Z score of 35.23 indicates that TRON is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 35.23, TRON belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 35.23
ROIC/WACCN/A
WACCN/A
TRON Yearly LT Debt VS Equity VS FCFTRON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

TRON has a Current Ratio of 0.01. This is a bad value and indicates that TRON is not financially healthy enough and could expect problems in meeting its short term obligations.
TRON has a Current ratio of 0.01. This is amonst the worse of the industry: TRON underperforms 93.94% of its industry peers.
TRON has a Quick Ratio of 0.01. This is a bad value and indicates that TRON is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.01, TRON is not doing good in the industry: 93.94% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
TRON Yearly Current Assets VS Current LiabilitesTRON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

1

3. Growth

3.1 Past

TRON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 129.57%, which is quite impressive.
EPS 1Y (TTM)129.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.45%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 37.25 indicates a quite expensive valuation of TRON.
The rest of the industry has a similar Price/Earnings ratio as TRON.
Compared to an average S&P500 Price/Earnings ratio of 27.20, TRON is valued a bit more expensive.
Industry RankSector Rank
PE 37.25
Fwd PE N/A
TRON Price Earnings VS Forward Price EarningsTRON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRON Per share dataTRON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for TRON!.
Industry RankSector Rank
Dividend Yield N/A

TRON INC

NASDAQ:TRON (9/16/2025, 8:00:01 PM)

After market: 3.05 +0.07 (+2.35%)

2.98

-0.02 (-0.83%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners13.92%
Inst Owner Change-61.09%
Ins Owners24.12%
Ins Owner Change4.4%
Market Cap755.34M
Analysts0
Price TargetN/A
Short Float %2.49%
Short Ratio2.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 37.25
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.08
EY2.68%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.69%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.01%
ROA(5y)N/A
ROE(3y)1.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 35.23
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)129.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y72.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y99.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.89%
OCF growth 3YN/A
OCF growth 5YN/A